New York City, NY -- (SBWIRE) -- 08/22/2013 -- StockMarketIntel.com issues a special report on the following stocks: Cirrus Logic, Inc. (NASDAQ:CRUS), PROLOR Biotech Inc (NYSEMKT:PBTH), PDL BioPharma Inc. (NASDAQ:PDLI), Repros Therapeutics Inc (NASDAQ:RPRX)
Cirrus Logic, Inc. (NASDAQ:CRUS) declined -0.29%, trading on 1.18M shares to end the trade at $20.42. If we look at its trading history of past 52 weeks, the share price suffered low of $16.46 on Jun 24, 2013 and was moved to maximum level of $45.49 on Sep 7, 2012.The stock changed hands in a range of $20.23 to $20.84, bringing its market capitalization at about $1.30B. Cirrus Logic, Inc. is a United States-based company, which supplies high-precision analog and digital signal processing components for audio and energy markets. The Companys products include analog-to-digital converters (ADCs), digital-to-analog converters (DACs), codecs that integrate ADCs.
Has CRUS Found The Bottom and Ready To Move Up? Find Out Here
PROLOR Biotech Inc (NYSEMKT:PBTH) loss of -1.13% to complete the trading session at $7.85 with a total volume of 1.18M shares.The stock, on average, trades on a volume of 274,402.00 shares. In the past 52 weeks, the share price has not declined below $4.25 and above $8.17.It floated in a range of $7.80 to $8.17 during last trading session with a beta value of 1.57.Its market capitalization now moved to about $501.26M. PROLOR Biotech, Inc. (Prolor) is a development-stage biopharmaceutical company, utilizing technology to develop longer-acting, versions of therapeutic proteins. The Company is using the carboxyl terminal peptide (CTP) technology to develop new versions of certain therapeutic proteins.
Has PBTH Found The Bottom And Ready To Gain Momentum? Find Out Here
PDL BioPharma Inc. (NASDAQ:PDLI) recorded a gain of 0.88% and was in a range of $7.92 -$8.09 before closing at $8.03. The share price hit its 52-week low of $6.50 on Jan 25, 2013 and $8.48 was the best price in the same period.The stock completed the day with a total volume of 1.17M shares versus an average volume of 1.91M shares. PDL BioPharma, Inc. (PDL) is a is a biotech company. PDL is engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies.
Will PDLI Continue To Move Higher? Find Out Here
Repros Therapeutics Inc (NASDAQ:RPRX) loss of -3.64% yesterday, bringing its market capitalization around $438.93M. The total number of shares changed hands during the session was 1.16M shares as compared to average trading volume of 363,583.00 shares.The share price after opening at $20.75 made a high of $20.95 and hovered above $18.98 to end the day at $19.08. Repros Therapeutics, Inc. is a United States-based company that develops products and services for the management of reproductive health. The Company's products include: contraceptives, vaccines for prostate cancer, enhanced topical treatment for genital herpes as well as treatments for male and female sexual dysfunction.
Will RPRX Get Buyers Even After The Recent Rally? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)